A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice
文献类型：期刊论文
| 作者 | Chen, Desu; Liao, Jiayu; Li, Na; Zhou, Caihong; Liu, Qing; Wang, Guangxing; Zhang, Rui; Zhang, Song; Lin, Lilin; Chen, Kaixian
|
| 刊名 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
 |
| 出版日期 | 2007-01-16 |
| 卷号 | 104期号:3页码:943-948 |
| 关键词 | diabetes metabolism therapeutics |
| ISSN号 | 0027-8424 |
| DOI | 10.1073/pnas.0610173104 |
| 文献子类 | Article |
| 英文摘要 | Peptidic mimics of the gut hormone glucagon-like peptide (GLIP) 1, exemplified by the recently approved drug exenatide, show promise as therapies for type 2 diabetes. Such "incretin mimetics" regulate glucose appearance in the plasma and can restore glucose-stimulated insulin secretion without excess risk of hypoglycemia. The need for injection, which may limit the use of peptidic GLP-1 receptor (GLP-1R) agonists, has driven largely unsuccessful efforts to find smaller molecules. The failure to identify orally effective agonists has instead promoted the indirect approach of inhibiting the GLP-1-degrading enzyme dipeptidyl peptidase IV. Here we report a nonpeptidic GLP-1R agonist with sufficient activity to evoke effects in whole animals, including antidiabetic efficacy in db/db mice. Two substituted cyclobutanes (S4P and Boc5) were developed after screening a compound library against a cell line stably cotransfected with GLP-1R and a cAMP-responsive reporter. Each bound to GLP-1R and increased intracellular cAMP. Agonist effects were blocked by the GLP-1R antagonist exendin(9-39). Boc5 amplified glucose-stimulated insulin secretion in isolated rat islets. Both i.p. and oral administration of Boc5 dose-dependently inhibited food intake in mice, an effect that could be blocked by pretreatment with exendin(9-39). Daily injections of BocS into db/db mice reduced HbA1c to nondiabetic values, an effect not observed in ad libitum-fed or pair-fed diabetic controls. Thus, Boc5 behaved as a full GLP-1 mimetic in vitro and in vivo. The chemical genus represented by Boc5 may prompt the exploration of orally available GLP-1R agonists with potential utility in diabetes and obesity. |
| WOS关键词 | IMPROVED GLYCEMIC CONTROL ; BETA-CELL MASS ; INSULIN SENSITIVITY ; ZUCKER RATS ; GLUCOSE-CONCENTRATIONS ; EXENDIN-4 ; PANCREAS ; WEIGHT ; EXPRESSION ; OB/OB |
| WOS研究方向 | Science & Technology - Other Topics |
| 语种 | 英语 |
| WOS记录号 | WOS:000243761100048 |
| 出版者 | NATL ACAD SCIENCES |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/273352]  |
| 专题 | 国家新药筛选中心 |
| 通讯作者 | Wang, Ming-Wei |
| 作者单位 | 1.Natl Ctr Drug Screening, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab New Drug Res, Shanghai 201203, Peoples R China |
| 推荐引用方式 GB/T 7714 | Chen, Desu,Liao, Jiayu,Li, Na,et al. A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,2007,104(3):943-948. |
| APA | Chen, Desu.,Liao, Jiayu.,Li, Na.,Zhou, Caihong.,Liu, Qing.,...&Wang, Ming-Wei.(2007).A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,104(3),943-948. |
| MLA | Chen, Desu,et al."A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice".PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 104.3(2007):943-948. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。